View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Gregory Ramirez
  • Gregory Ramirez

COMPUGROUP MEDICAL - BUY | EUR66 No outstanding growth, but limited ri...

COMPUGROUP MEDICAL - BUY | EUR66 No outstanding growth, but limited risk Unsurprisingly, medium-term targets are confirmed Stable and secular growth drivers, unlikely to be hit by a recession Significant adj. EBITDA margin levers

 PRESS RELEASE

DGAP-News: CompuGroup Medical bestätigt Mittelfristziele anlässlich de...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Sonstiges CompuGroup Medical bestätigt Mittelfristziele anlässlich des Kapitalmarkttages 01.09.2022 / 09:48 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CGM auf gutem Weg zu starkem Umsatzwachstum im Jahr 2022 Organisches Umsatzwachstum von durchschnittlich über 5 % pro Jahr bis 2025 bestätigt Verbesserung der bereinigten EBITDA-Marge nach Investitionsphase auf rund 27 % in 2025 erwartet Alle Segmente überzeugen mit Umsatz- und Margenwachstum Kürzlich angehobene Prog...

 PRESS RELEASE

DGAP-News: CompuGroup Medical confirms mid-term ambition at the Capita...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous CompuGroup Medical confirms mid-term ambition at the Capital Markets Day 01.09.2022 / 09:48 CET/CEST The issuer is solely responsible for the content of this announcement. CGM well on track for strong revenue growth in 2022 Mid-term organic revenue growth of more than 5 % CAGR reconfirmed Adjusted EBITDA Margin improvement post investment phase towards 27 % by 2025 Every segment delivers on revenue growth and margin expansion Recently raised guidance for 2022 confirmed Koblenz. CompuGroup Medic...

Aurelien Sivignon
  • Aurelien Sivignon

CompuGroup Medical SE : Conference call feedback: confident on a back-...

>Main points from yesterday’s conference call - Q2 and H1 results Yesterday morning, CompuGroup published its Q2 results (cf. link to our First Take). In line with Q1, the group posted growth of +10% y-o-y in Q2 (+3% org.) with sales of € 265m, 3% above ODDO BHF/consensus forecasts. Adjusted EBITDA was € 54m in Q2, i.e. a 100bp y-o-y deterioration in the margin to 20.2%. Whilst the AIS activity posted a solid 200bp improvement in its margin (27%), it was above all th...

Aurelien Sivignon
  • Aurelien Sivignon

CompuGroup Medical SE : Feedback conf. call : confiance pour une fin d...

>Principaux points de la conférence call d’hier - Résultats T2 et S1. CompuGroup a publié ses résultats T2 hier matin (cf. lien first take). A l’instar du T1, la croissance du CA est ressortie à 10% y-o-y au T2 (+3% org.) à 265 M€, supérieur de 3% aux attentes ODDO BHF/consensus. L’EBITDA ajusté a atteint 54 M€ au T2 soit une marge de 20.2% en baisse de 100 pb y-o-y. Alors que le segment AIS affiche une solide progression de 200 pb de sa marge (27%), c’est surtout le...

Aurelien Sivignon
  • Aurelien Sivignon

CompuGroup Medical SE : Q2 results above consensus. FY guidance raised...

>Q2 top line and adjusted EBITDA better than consensus expectations - CompuGroup published this morning its Q2 results which were above the consensus. Revenues were up 10% y-o-y, above ODDO BHF/consensus expectations by 3%. Adjusted for M&A contributions, organic growth came in at 3% in Q2 after 5.4% in Q1. Q2 revenue growth was supported by a good performance in the CHS segment (+6% beat on consensus) and PCS segment (+6% beat on consensus) whereas the AIS segment (a...

Aurelien Sivignon
  • Aurelien Sivignon

CompuGroup Medical SE : Q2 results above consensus. FY guidance raised...

>Q2 top line and adjusted EBITDA better than consensus expectations - CompuGroup published this morning its Q2 results which were above the consensus. Revenues were up 10% y-o-y, above ODDO BHF/consensus expectations by 3%. Adjusted for M&A contributions, organic growth came in at 3% in Q2 after 5.4% in Q1. Q2 revenue growth was supported by a good performance in the CHS segment (+6% beat on consensus) and PCS segment (+6% beat on consensus) whereas the AIS segment (a...

Gregory Ramirez
  • Gregory Ramirez

CompuGroup Medical | Buy | TP EUR66 Decent quarter, profitability ac...

CompuGroup Medical | Buy | TP EUR66 Decent quarter, profitability acceleration to come in H2

 PRESS RELEASE

DGAP-News: CompuGroup Medical legt in allen Segmenten zu – Prognose 20...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Halbjahresergebnis CompuGroup Medical legt in allen Segmenten zu – Prognose 2022 angehoben 04.08.2022 / 07:23 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 10 % Wachstum in erster Jahreshälfte 2022 auf EUR 517 Mio. Gesamtumsatz 8 % Wachstum des bereinigten EBITDA in den ersten sechs Monaten Anstieg der wiederkehrenden Umsätze auf 69 % Anteil am Gesamtumsatz unterstreicht Stabilität des Geschäftsmodells Prognose für 2022 angehoben und mittelfristige Ziele bestätigt Koblenz. Co...

 PRESS RELEASE

DGAP-News: CompuGroup Medical delivers across all segments – guidance ...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Half Year Results CompuGroup Medical delivers across all segments – guidance 2022 raised 04.08.2022 / 07:23 The issuer is solely responsible for the content of this announcement. 10 % growth in first half of 2022 with revenues of EUR 517 million 8 % growth in adjusted EBITDA after first six months of 2022 Growing share of recurring revenues at 69 % underlines resilience of business model Guidance for 2022 raised and mid-term targets confirmed   Koblenz. CompuGroup Medical SE & Co. KGaA (CGM), one of the world...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

DGAP-News: CompuGroup Medical ernennt CFO Michael Rauch zum Sprecher d...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Personalie CompuGroup Medical ernennt CFO Michael Rauch zum Sprecher der geschäftsführenden Direktoren 02.06.2022 / 21:04 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Verwaltungsrat und CEO Dr. Dirk Wössner einigen sich auf Beendigung des Vertrages zum 30. Juni 2022 CFO Michael Rauch wird zum Sprecher der geschäftsführenden Direktoren ernannt und erhält als primus inter pares Sitz im Verwaltungsrat Reduzierung der geschäftsführenden Direktoren von sieben auf fünf – Frank Breche...

 PRESS RELEASE

DGAP-News: CompuGroup Medical appoints CFO Michael Rauch as Spokesman ...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel CompuGroup Medical appoints CFO Michael Rauch as Spokesman for the Managing Directors 02.06.2022 / 21:04 The issuer is solely responsible for the content of this announcement. Administrative Board and CEO Dr. Dirk Wössner mutually agree on termination of contract as of June 30, 2022 CFO Michael Rauch is appointed Spokesman of the Managing Directors as primus inter pares and takes a seat on the Administrative Board Reduction of the number of Managing Directors from seven to five – Frank Brecher will r...

 PRESS RELEASE

DGAP-News: CompuGroup Medical reports record results at virtual Annual...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM CompuGroup Medical reports record results at virtual Annual General Meeting and confirms growth targets 19.05.2022 / 13:42 The issuer is solely responsible for the content of this announcement. Koblenz. CompuGroup Medical SE & Co. KGaA, one of the world's leading e-health companies, held its Annual General Meeting today, once again in a virtual setting. All agenda items were approved by a majority. Management also confirmed the guidance for the current year and medium-term growth targets. The attendees ...

 PRESS RELEASE

DGAP-News: CompuGroup Medical berichtet auf virtueller Hauptversammlun...

DGAP-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Hauptversammlung CompuGroup Medical berichtet auf virtueller Hauptversammlung über Rekordergebnis und bekräftigt Wachstumsziele 19.05.2022 / 13:42 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Koblenz. CompuGroup Medical SE & Co. KGaA, eines der führenden E-Health Unternehmen weltweit, hat heute seine ordentliche Hauptversammlung abgehalten, die erneut als virtuelle Veranstaltung durchgeführt wurde. Sämtliche Tagesordnungspunkte wurden mehrheitlich beschlossen. Das Management bes...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch